Azora Therapeutics, Inc. (DE) SEC filings ADIL

Azora Therapeutics, Inc. (DE) has 575 filings in SEC EDGAR's recent list, going back to Mar 16, 2011. Its latest annual report, Form ARS, was filed on Aug 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (officer or director change, bylaw or fiscal year change, shareholder vote results, regulation fd disclosure). The company's fiscal year ends on December 31.

Azora Therapeutics, Inc. (DE) SEC filings
Form Description Filed Period
4 Insider transaction Nov 4, 2026 Nov 2, 2026
4 Insider transaction Nov 4, 2026 Nov 2, 2026
4 Insider transaction Nov 3, 2026 Nov 2, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 3, 2026 —
4 Insider transaction Oct 30, 2026 Oct 28, 2026
3 Initial insider ownership Oct 30, 2026 Oct 28, 2026
3 Initial insider ownership Oct 30, 2026 Oct 28, 2026
4 Insider transaction Sep 21, 2026 Sep 17, 2026
4 Insider transaction Jul 16, 2026 Jul 14, 2026
4 Insider transaction Jul 13, 2026 Jul 9, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 1, 2026 —
4 Insider transaction Jul 1, 2026 Jun 29, 2026
3 Initial insider ownership Jun 29, 2026 Jun 24, 2026
SCHEDULE 13G Ownership over 5% (passive) Jun 24, 2026 —
4 Insider transaction Jun 16, 2026 Jun 11, 2026
3 Initial insider ownership Jun 16, 2026 Jun 11, 2026
4 Insider transaction Jun 16, 2026 Jun 12, 2026
3 Initial insider ownership Jun 16, 2026 Jun 11, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
4 Insider transaction Apr 9, 2026 Apr 7, 2026
4 Insider transaction Apr 9, 2026 Apr 7, 2026
4 Insider transaction Apr 9, 2026 Apr 7, 2026
4 Insider transaction Apr 9, 2026 Apr 7, 2026
4 Insider transaction Apr 9, 2026 Apr 7, 2026
4 Insider transaction Apr 9, 2026 Apr 7, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 18, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jun 23, 2025 —
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Dec 5, 2024 Dec 5, 2024
4 Insider transaction Nov 18, 2024 Nov 16, 2024
3 Initial insider ownership Nov 18, 2024 Nov 16, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
4 Insider transaction Oct 3, 2023 Sep 29, 2023
4 Insider transaction Jun 2, 2023 May 23, 2023
4 Insider transaction May 25, 2023 May 23, 2023
4 Insider transaction May 25, 2023 May 23, 2023
4 Insider transaction May 25, 2023 May 23, 2023
4 Insider transaction May 25, 2023 May 23, 2023
4 Insider transaction May 25, 2023 May 23, 2023
4 Insider transaction May 25, 2023 May 23, 2023
4 Insider transaction May 25, 2023 May 23, 2023
4 Insider transaction May 25, 2023 May 23, 2023
4 Insider transaction Jan 3, 2023 Dec 30, 2022
4 Insider transaction Sep 20, 2022 Sep 19, 2022
4 Insider transaction Aug 23, 2022 Aug 22, 2022
4 Insider transaction Aug 22, 2022 Aug 18, 2022
4 Insider transaction Jun 28, 2022 Jun 27, 2022
4 Insider transaction Feb 25, 2022 Feb 23, 2022
4 Insider transaction Feb 25, 2022 Feb 23, 2022
4 Insider transaction Feb 25, 2022 Feb 23, 2022
4 Insider transaction Feb 25, 2022 Feb 23, 2022
4 Insider transaction Feb 25, 2022 Feb 23, 2022
4 Insider transaction Feb 25, 2022 Feb 23, 2022
4 Insider transaction Feb 25, 2022 Feb 23, 2022
4 Insider transaction Feb 25, 2022 Feb 23, 2022
4 Insider transaction Feb 25, 2022 Feb 23, 2022
SC 13D/A Amended ownership over 5% (active) Feb 18, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2022 —
4 Insider transaction Jan 3, 2022 Dec 30, 2021
4 Insider transaction Dec 23, 2021 Dec 23, 2021
4 Insider transaction Dec 8, 2021 Dec 7, 2021
4 Insider transaction Dec 1, 2021 Nov 29, 2021
4 Insider transaction Nov 30, 2021 Nov 26, 2021
4 Insider transaction Nov 3, 2021 Nov 2, 2021
3 Initial insider ownership Nov 3, 2021 Nov 2, 2021
4 Insider transaction Oct 6, 2021 Oct 4, 2021
SC 13G/A Amended ownership over 5% (passive) Aug 18, 2021 —
SC 13G Ownership over 5% (passive) Aug 13, 2021 —
SC 13D/A Amended ownership over 5% (active) Aug 13, 2021 —
4 Insider transaction Apr 8, 2021 Apr 6, 2021
SC 13G/A Amended ownership over 5% (passive) Feb 16, 2021 —
4 Insider transaction Feb 10, 2021 Feb 8, 2021
4 Insider transaction Feb 10, 2021 Feb 8, 2021
4 Insider transaction Feb 10, 2021 Feb 8, 2021
4 Insider transaction Feb 10, 2021 Feb 8, 2021
4 Insider transaction Feb 10, 2021 Feb 8, 2021
4 Insider transaction Feb 10, 2021 Feb 8, 2021
4 Insider transaction Feb 10, 2021 Feb 8, 2021
SC 13D/A Amended ownership over 5% (active) Feb 8, 2021 —
4 Insider transaction Jan 28, 2021 Jan 26, 2021
4 Insider transaction Jan 28, 2021 Jan 26, 2021
SC 13D/A Amended ownership over 5% (active) Dec 11, 2020 —
4/A Filing Nov 25, 2020 Nov 12, 2018
4/A Filing Nov 25, 2020 Jul 31, 2018
4 Insider transaction Nov 25, 2020 Nov 23, 2020
4 Insider transaction Aug 24, 2020 Aug 20, 2020
SC 13G Ownership over 5% (passive) Jun 19, 2020 —
SC 13G Ownership over 5% (passive) Jun 18, 2020 —
4 Insider transaction May 20, 2020 May 19, 2020
3 Initial insider ownership May 20, 2020 May 19, 2020
4 Insider transaction Mar 30, 2020 Mar 27, 2020
4 Insider transaction Mar 27, 2020 Mar 25, 2020
4 Insider transaction Mar 5, 2020 Mar 3, 2020
4 Insider transaction Mar 5, 2020 Mar 3, 2020
4 Insider transaction Mar 5, 2020 Mar 3, 2020
4 Insider transaction Mar 5, 2020 Mar 3, 2020
4 Insider transaction Mar 5, 2020 Mar 3, 2020
4 Insider transaction Mar 5, 2020 Mar 3, 2020
4 Insider transaction Mar 5, 2020 Mar 3, 2020
SC 13G/A Amended ownership over 5% (passive) Jan 21, 2020 —
4 Insider transaction Dec 13, 2019 Dec 12, 2019
4 Insider transaction Oct 4, 2019 Oct 2, 2019
4 Insider transaction Apr 1, 2019 Mar 28, 2019
SC 13D/A Amended ownership over 5% (active) Apr 1, 2019 —
SC 13D/A Amended ownership over 5% (active) Mar 29, 2019 —
4 Insider transaction Mar 26, 2019 Mar 24, 2019
4 Insider transaction Mar 12, 2019 Mar 10, 2019
4 Insider transaction Mar 12, 2019 Mar 10, 2019
SC 13G Ownership over 5% (passive) Mar 1, 2019 —
SC 13D Ownership over 5% (active) Nov 14, 2018 —
SC 13D Ownership over 5% (active) Nov 14, 2018 —
SC 13D Ownership over 5% (active) Nov 14, 2018 —
SC 13D Ownership over 5% (active) Nov 14, 2018 —
4 Insider transaction Nov 13, 2018 Nov 12, 2018
4 Insider transaction Nov 13, 2018 Nov 12, 2018
4 Insider transaction Nov 13, 2018 Nov 12, 2018
4 Insider transaction Nov 13, 2018 Nov 12, 2018
4 Insider transaction Aug 2, 2018 Jul 31, 2018
4 Insider transaction Aug 2, 2018 Jul 31, 2018
4 Insider transaction Aug 2, 2018 Jul 31, 2018
4 Insider transaction Aug 2, 2018 Jul 31, 2018
4 Insider transaction Aug 2, 2018 Jul 31, 2018
4 Insider transaction Aug 2, 2018 Jul 31, 2018
4 Insider transaction Aug 2, 2018 Jul 31, 2018
3 Initial insider ownership Jul 26, 2018 Jul 26, 2018
3 Initial insider ownership Jul 26, 2018 Jul 26, 2018
3 Initial insider ownership Jul 26, 2018 Jul 26, 2018
3 Initial insider ownership Jul 26, 2018 Jul 26, 2018
3 Initial insider ownership Jul 26, 2018 Jul 26, 2018
3 Initial insider ownership Jul 26, 2018 Jul 26, 2018
3 Initial insider ownership Jul 26, 2018 Jul 26, 2018
3 Initial insider ownership Jul 26, 2018 Jul 26, 2018

Showing 146 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
AZR (Nasdaq), ADIL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Encino, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1513525
Former names
ADIAL PHARMACEUTICALS, INC. (until Oct 30, 2026); Adial Pharmaceuticals, L.L.C. (until Sep 28, 2017); ADial Pharmaceuticals, L.L.C. (until Sep 28, 2017)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.